CEDILANID-D |
DESLANOSIDE |
DESACETYL-LANATOSIDE C |
DESACETYLLANATOSIDE C |
DESLANOSIDUM |
CEDILANID-D (TN) |
DEACETYLLANATOSIDE C |
GLUCODIGOXIN |
(3BETA,5BETA,12BETA)-3-{[BETA-D-GLUCOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-12,14-DIHYDROXYCARD-20(22)-ENOLIDE |
3-[(O-BETA-D-GLUCOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-BETA-D-RIBO-HEXOPYRANOSYL)OXY]-12,14-DIHYDROXY-3BETA,5BETA,12BETA-CARD-20(22)-ENOLIDE |
DESLANOSIDO |
CEDILANIDEĀ® |
chembl:CHEMBL1614 |
drugbank:01078 |
pubchem.compound:28620 |
chemidplus:17598-65-1 |
rxcui:3248 |
FDA Approval | Approved before 1982 |
Drug Class | small molecule |
Drug Indications | Cardiotonic Agents |
Drug Indications | Antiarrhythmia Agents |
Year of Approval | approved before 1982 |
Drug Class | cardiotonic agents |
Drug Class | anti-arrhythmia agents |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium/potassium-transporting ATPase inhibitor |
Direct Interaction | yes |
DESLANOSIDE | Primary Drug Name |
Drug Class | anti-arrhythmia agents |
Drug Class | cardiotonic agents |
Year of Approval | approved before 1982 |
Drug Indications | Antiarrhythmia Agents |
Drug Indications | Cardiotonic Agents |
Drug Class | small molecule |
D07TGN | TTD Drug ID |
CHEMBL1614 | ChEMBL Drug ID |